RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 3.643
NA - Nord America 2.684
AS - Asia 583
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 6.920
Nazione #
US - Stati Uniti d'America 2.673
IE - Irlanda 1.590
GB - Regno Unito 440
FR - Francia 346
IT - Italia 326
DE - Germania 301
SG - Singapore 255
CN - Cina 249
UA - Ucraina 238
SE - Svezia 129
GR - Grecia 120
FI - Finlandia 79
TR - Turchia 50
CZ - Repubblica Ceca 21
BE - Belgio 20
KR - Corea 17
CA - Canada 10
NL - Olanda 7
RU - Federazione Russa 7
EU - Europa 4
RO - Romania 4
ES - Italia 3
PL - Polonia 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
HK - Hong Kong 2
IN - India 2
JP - Giappone 2
MY - Malesia 2
AL - Albania 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
IR - Iran 1
KE - Kenya 1
MX - Messico 1
NG - Nigeria 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.920
Città #
Dublin 1.588
Chandler 513
Jacksonville 470
Princeton 230
Roxbury 191
Singapore 153
Bremen 132
Medford 125
Cambridge 114
Beijing 79
Ann Arbor 77
Wilmington 71
Boardman 62
Des Moines 49
San Mateo 49
Woodbridge 34
Caserta 33
Naples 33
New York 30
Jinan 24
Munich 21
Brno 20
Brussels 20
Lappeenranta 17
Seoul 16
Shenyang 14
Nanchang 13
Changsha 12
Düsseldorf 12
Norwalk 12
Houston 11
Marano Di Napoli 11
Napoli 11
Hebei 10
Helsinki 10
Nanjing 10
Zhengzhou 10
Milan 9
Palermo 8
Rome 8
Afragola 7
Ashburn 7
Florence 7
Lanzhou 7
Mountain View 7
Philadelphia 7
Redwood City 7
Tianjin 7
Guangzhou 6
Haikou 6
Hangzhou 6
Taiyuan 6
Istanbul 5
Laurel 5
Taizhou 5
Auburn Hills 4
Cerro Maggiore 4
Los Angeles 4
Toronto 4
Trumbull 4
Atlanta 3
Avellino 3
Deventer 3
Fairfield 3
Forio 3
Gatchina 3
London 3
Ningbo 3
Nocera Superiore 3
Pagani 3
Pelago 3
Rostock 3
Shanghai 3
Tappahannock 3
Acerra 2
Amsterdam 2
Bacoli 2
Bath 2
Brighton 2
Buffalo 2
Camden 2
Cluj-Napoca 2
Collecchio 2
Dalmine 2
Genoa 2
Gragnano 2
Ischia 2
Kuching 2
Lyon 2
Manduria 2
Marigliano 2
Messina 2
Mirandola 2
New Orleans 2
Padova 2
Phoenix 2
Pievepelago 2
Pozzuoli 2
Sparanise 2
Thessaloniki 2
Totale 4.521
Nome #
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 72
Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. 70
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 68
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 66
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 65
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 65
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 65
Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. 65
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 64
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 64
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 64
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 64
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 63
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 62
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 62
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 61
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 59
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 59
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 59
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 59
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 59
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 58
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 58
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 58
Superior vena cava thrombosis after intravascular AICD lead extraction: a case report 57
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 57
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 56
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 56
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 56
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 54
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 54
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 53
Coronary sinus spasm during left ventricular lead implantation for biventricular pacing 52
Giant coronary sinus in patient with double superior vena cava demonstrated by multislice computed tomography 52
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 52
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 52
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 51
Influence of biventricular pacing on myocardial dispersion of repolarization in dilated cardiomyopathy patients 51
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 50
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 50
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 50
Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review 45
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 44
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience 44
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 44
Biventricular pacing and heterogeneity of ventricular repolarization in heart failure patients 44
Heart rate variability, obesity, and bariatric-induced weight loss: the importance of selection criteria 43
Cardiopulmonary resuscitation in pectus excavatum patients: is it time to say more? 43
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients 43
Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy 43
Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study 42
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 42
Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy? 41
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 41
Role of electrophysiological evaluation for the best device choice to prevent sudden cardiac death in patients with Myotonic Dystrophy Type 1 and Emery Dreifuss Muscular Dystrophy 41
Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. 40
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. 40
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 40
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study 39
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 39
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 39
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 38
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 38
ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. 37
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence 37
Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications 37
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 37
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 37
DOES HIGH PERCENTAGE OF RIGHT VENTRICULAR PACING HAVE AN INFLUENCE ON PAROXYSMAL ATRIAL FIBRILLATION INCIDENCE IN MYOTONIC DYSTROPHY TYPE 1 PATIENTS? 36
Syncope in the elderly patient: From epidemiology to treatment. 36
Heart rate variability analysis in postural orthostatic tachycardia syndrome: a case report 35
The efficacy of Bachmann's bundle stimulaton in Myotonic Dystrophy type 1 patients 34
Does Bachmann bundle's pacing prevent atrial fibrillation in Myotonic Dystrophy type 1 patients? A twelve-months follw-up study. 34
The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1 34
Atrial electromechanical delay in myotonic dystrophy type 1 patients 34
Anti-arrhythmic properties of non-antiarrhythmic medications 34
Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence 33
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 33
Voltage-directed cavo-tricuspid isthmus ablation using a novel ablation catheter mapping technology in a myotonic dystrophy type i patient 33
The clinical performance of dabigatran in the Italian real-life experience 33
Seasonal trend of ventricular arrhythmias in a nationwide remote monitoring database of implantable defibrillators and cardiac resynchronization devices 33
Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting 33
Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients 32
Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C 32
Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database 32
Atrial fibrillation and beta thalassemia major: The predictive role of the 12-lead electrocardiogram analysis 32
Optimal left ventricular lead placement for cardiac resynchronization therapy in postmyocardial infarction patients 32
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders 32
Appropriate timing of electrophysiological study in myotonic dystrophy type 1: unsolved question 32
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study 31
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 31
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 30
Temperament and character personality dimensions in nitrate-tilt-induced vasovagal syncope patients 30
Which is the true epidemiology of left ventricular dysfunction in patients with myotonic dystrophy type 1? 30
Budget impact analysis of rivaroxaban vs. warfarin anticoagulation strategy for direct current cardioversion in non-valvular atrial fibrillation patients: the MonaldiVert Economic Study 30
Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1 30
Cardiovascular comorbidities and pharmacological treatments of covid-19 patients not requiring hospitalization 30
Heart rate variability analysis in postural orthostatic tachycardia sindrome: a case report 29
Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study 29
Direct Oral Anticoagulants in Octogenarians With Atrial Fibrillation: It Is Never Too Late 29
Totale 4.538
Categoria #
all - tutte 40.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020539 0 0 69 21 69 26 139 34 99 26 39 17
2020/2021855 58 4 59 79 181 10 124 58 13 73 168 28
2021/20221.414 52 18 34 46 400 4 8 33 40 147 200 432
2022/20232.528 258 29 39 183 238 174 9 114 1.385 28 38 33
2023/20241.116 71 39 50 65 450 51 44 20 11 29 79 207
2024/202578 31 47 0 0 0 0 0 0 0 0 0 0
Totale 7.336